Endovia Health Sciences vs LQR House
EDVA and YHC side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EDVA and YHC compare
LQR House is the larger company, worth 2.9 times as much as Endovia Health Sciences ($355K against $121K).
LQR House scores higher on the StockData Score (3 against 0 for Endovia Health Sciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EDVA | YHC |
|---|---|---|
| Size and price | ||
| Market cap | $121K | $355K |
| Share price | $0.161 | $1.65 |
| Change, 1 year | −96.3% | −98.1% |
| Change, 5 years | −99.9% | – |
| Beta (5Y) | 1.00 | 0.93 |
| Employees | 1 | 4 |
| StockData Score | ||
| Total score | 0 | 3 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 0 |
| Health score | 0 | 0 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 0.3× |
| P/B | – | 0.0× |
| Growth | ||
| Revenue growth (TTM) | – | −49.6% |
| Revenue growth, 5Y average | −49.8% | – |
| Profitability | ||
| Gross margin | – | 6.5% |
| Operating margin | – | −908% |
| Net margin | – | −1589% |
| Return on equity | – | −88.2% |
| Return on invested capital | – | −22.0% |
| Financial health | ||
| Debt / equity | – | 1.51 |
| Interest coverage | −5.7× | – |
| Current ratio | 0.05 | 0.96 (better) |
| Altman Z-score | −302.17 | −0.91 (better) |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 37.0% | – |
| Insider net buying, 12 months | – | $1.8M |
Go deeper
- EDVA stock overview
- EDVA income statement
- EDVA valuation and score
- YHC stock overview
- YHC income statement
- YHC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.